Back to School During a Pandemic Year 2022-2023 - CMDHD/MMDHD/DHD#10 Jennifer Morse, MD, MPH, FAAFP Medical Director
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Back to School During a Pandemic Year 2022-2023 Jennifer Morse, MD, MPH, FAAFP Medical Director CMDHD/MMDHD/DHD#10
MDHHS Back to School Kickoff Event (https://forms.office.com/Pages/ResponsePage.aspx?id=h3 D71Xc3rUKWaoku9HIl0WdlyfL5- pdDsae6UDUzlypUMEdXQlJZWU9LSE5LM1JWUFNORzRL VkVJRC4u)
Good Article: Covid Funding Pries Open a Door to Improving Air Quality in Schools https://khn.org/news/article/covid-funding-pries- open-a-door-to-improving-air-quality-in-schools/
Pampati S, Rasberry CN, McConnell L, et al. Ventilation Improvement Strategies Among K–12 Public Schools — The National School COVID-19 Prevention Study, United States, February 14–March 27, 2022. MMWR Morb Mortal Wkly Rep 2022;71:770–775. DOI: http://dx.doi.org/10.15585/mmwr.mm7123e2
Masking and Mitigation Considerations Calculator • To assist school districts with mitigation strategy decisions as they navigate the COVID-19 pandemic, The ABC Science Collaborative has developed a Masking and Mitigation Considerations Calculator (MC2). By entering a district's specific size and current community case rates, the MC2 will estimate the impact of mitigation strategy decisions on the school district and community. https://abcsciencecollaborative.org/
School Guidance Materials for 2022-2023: Local Public Health Department Guidance • No new recommendations or requirements • Three guidance documents sent earlier this week: o 2022-2023 PreK-12 Public Health Guidance PDF o 07-2022 Parent Illness Guide o School Line list excel document o Communication document • Attempt to incorporate COVID-19 into other infectious disease prevention and response
2022-2023 PreK-12 Public Health Guidance PDF • Recommend the management of COVID-19 transition from a pandemic emergency response model toward a more standard approach used in the management and control of other respiratory viral diseases, such as influenza. o Modifications may be needs based on variations in COVID-19 levels and the appearance of more virulent or contagious variants o Focus should be on basic illness prevention and detecting and responding to in-school clusters of cases, ongoing transmission in the school, and outbreaks. • Management will rely less on things like case investigation, contact tracing, and quarantining of students or staff following school exposures.
10 Basic Public Health Recommendations 1. Require sick students and staff to stay home (see 07-2022 Parent Illness Guide) 2. Report Appropriate Information to the Local Health Department 3. Request Information from Parents and Staff Regarding Illnesses (see School Line list excel document) 4. Monitor Community Conditions and Respond Accordingly (see Considerations for School Administrators Regarding Policy Changes to School Infection Control Measures, such as Mask Use) 5. Incorporate COVID-19 Testing into Your Response Plan 6. Watch Closely for Signs of Illness Clusters or Outbreaks 7. Respond Appropriately to Clusters and Outbreaks 8. School Closure Should Be a Last Resort 9. Be prepared to support students, families, and educators during illness and closures 10. Have a communication plan (see Communication document)
07-2022 Parent Illness Guide TYPO • If your child tests positive for COVID-19: o Tell your child’s of school.
School Line list excel document A resource to assist with tracking call-ins and illness, not a requirement
COMMUNICATION TOOLS • COVID-19 Communications Tool Kit https://www.nspra.org/covid-19-communications-tool-kit • Covid-19 testing communications toolkit https://www.covidtestingtoolkit.org/ • Communications for COVID Testing in Schools https://www.openandsafeschools.org/communications#communications-templates-&-examples • CDC sample letters for school testing programs https://www.cdc.gov/coronavirus/2019- ncov/community/schools-childcare/letters-for-schools.html • Letters for other health issues (consult with your local health department for help editing letters, letters about additional illnesses, and www.cdc.gov for additional information on each topic): o Giardia Letter to Daycare Director o HFMD Letter to Parents o Influenza Letter to Parents o Norovirus Letter to Parents o Pertussis Letter to Parents o Pertussis Letter to School Staff o MRSA Letter to Parents o Chickenpox Exclusion Letter • Letters for COVID-19 Isolation and Exposure o Isolation Guidance Letter to Parents/Guardians of Students with COVID-19 o COVID-19 General Exposure Notification
Considerations for School Administrators Regarding Policy Changes to School Infection Control Measures, such as Mask Use (located at end of 2022-2023 PreK-12 Public Health Guidance PDF) 1. What does the available data show regarding the community and district prevalence and transmission? 2. What is the risk tolerance for the possibility of increasing case numbers and necessary isolation in your students and staff? 3. What is the current COVID-19 or influenza vaccination status of students and staff within individual schools and across the district, and what is the current vaccine coverage for the surrounding community? 4. What more planning is necessary to address the needs of students and staff who may be at greater risk for adverse health outcomes? 5. What added guidance is necessary to ensure support for students and staff who may wish to continue mask wearing? 6. What processes need to be in place for continuous risk assessment and prompt decision-making about respiratory illness policies and mitigation strategies (including mask use) going forward? What advanced contingency planning needs to occur to prepare for potential surges and/or outbreaks? Adapted from: “Considerations for Boards of Education, District Administrators, and other Local Decision-Makers Regarding Potential Changes to School COVID-19 Policies and Practices”, Connecticut Department of Public Health
School Guidance Materials for 2022-2023: MDHHS (subject to updates) https://www.michigan.gov/coronavirus/resources/k-12-school-opening-guidance • MI Safe Schools Testing Program https://www.michigan.gov/coronavirus/resources/k-12-school-opening-guidance/mi-safe-schools- testing-program • Community Based Pop-Up Rapid Antigen Testing Events https://www.michigan.gov/coronavirus/resources/k-12-school-opening- guidance/resources/2-row-resources/community-based-pop-up-rapid-antigen-testing-events • MI Safer Schools Guidance for K-12 School Settings in a COVID-19 Recovery Phase https://www.michigan.gov/coronavirus/- /media/Project/Websites/coronavirus/Folder7/MI_Safer_Schools_Guidance_for_Managing_Students_Exposed_to_COVID- 19.pdf?rev=93ae3725e236441b9e238f9bc0ac4597&hash=A63762F5CE7B001AA5ADC0155C2ADC78 • SCHOOL GUIDANCE For School Administrator and Local Public Health Coordination https://www.michigan.gov/coronavirus/- /media/Project/Websites/coronavirus/School-Guidance---For-School-Administrator-and-Local-Public-Health-Coordinator- (3).pdf?rev=5f8309ec71b44b52961e5b13d19b7deb&hash=C0B21E76B5EE7A6C18334330B6BF9A90 • Recommendations for Safer School Operations during COVID-19 https://www.michigan.gov/coronavirus/- /media/Project/Websites/coronavirus/k12-Schools/COVID-19-Guidance-for-Operating-Schools-Safely---April- 2022.pdf?rev=e548b8831c6d48dcb6a3f87aa7801829 • Managing Communicable Diseases in Schools https://www.michigan.gov/coronavirus/- /media/Project/Websites/mdhhs/Folder2/Folder88/Folder1/Folder188/Managing_CD_in_Schools_FINAL.PDF?rev=e7997871809e4ca abd00a2e9775de82f • CDC Schools, Child Care, and Colleges COVID-19 Guidance https://www.cdc.gov/coronavirus/2019-ncov/community/schools- childcare/index.html
School Guidance Materials for 2022-2023: MDHHS https://www.michigan.gov/coronavirus/- /media/Project/Websites/coronavirus/Folder6/School_Quarantine_Guidance_v15.png?rev=16a04499cfec4e959de27ebb2e53aefa
CURRENT DATA End of July
Also found through: https://www.michigan.gov /coronavirus/stats CLICK ON K-12 Aged ISD Reporting https://www.michigan.gov/coronavirus/stats/k-to-12-aged-isd-reporting
Also found through: https://www.michigan. gov/coronavirus/stats CLICK ON K-12 Aged ISD Reporting https://www.michigan.gov/coronavirus/stats/k-to-12-aged-isd-reporting
https://www.michigan.gov/coronavirus
https://www.michigan.gov/coronavirus
July 28, 2022 August 2, 2022 https://www.michigan.gov/coronavirus/stats/data-and-modeling-updates
July 1 August 1
MONKEYPOX
About Monkeypox • Monkeypox is a rare but potentially serious disease that typically begins with a flu-like illness and swelling of the lymph nodes and progresses to include a widespread rash on the face and body. o However, in recent cases, patients have developed rashes without having flu-like symptoms first. • Monkeypox is caused by a virus that is in the same family as the virus that causes smallpox, but it typically results in a milder infection. • Most infections last 2-4 weeks and resolve without specific treatment. • Monkeypox is caused by a virus that can spread from animals to people. It can spread between people when someone has contact with someone who is infected with monkeypox or touches materials that are contaminated with the virus. • Monkeypox can spread to anyone through: o Direct contact with monkeypox rash or scabs on a person’s skin. o Contact with objects, fabrics (clothing, bedding, or towels), and surfaces that have been used by someone with monkeypox. o Contact with respiratory secretions during prolonged, face-to-face contact. o During intimate contact, due to the close contact involved and contact with bedding, clothing, etc. It is not considered a sexually transmitted infection (STI).
About Monkeypox • The rash can look like pimples or blisters and may be painful or itchy. o The sores typically go through several stages, including scabs, before healing. o Sores may be inside the body, including the mouth, vagina, or anus. • Monkeypox can be spread from the time symptoms start until all sores have healed and a fresh layer of skin has formed. • The illness may last for up to 2–4 weeks and Titanji, Boghuma K., et al. "Monkeypox: A Contemporary Review for usually resolves without specific treatment. Healthcare Professionals." Open Forum Infectious Diseases. Vol. 9. No. 7. Oxford University Press, 2022. • For more information on symptoms, see www.cdc.gov/poxvirus/monkeypox/sympto ms.html.
As Of August 2nd Number of Ohio 30 State Cases Nevada 25 New York 1617 Rhode Island 24 California 826 South Carolina 23 Illinois 533 Wisconsin 19 Texas 485 Puerto Rico 19 Florida 480 Alabama 19 Georgia 455 New Hampshire 13 District Of Columbia 248 Oklahoma 10 Pennsylvania 170 New Mexico 10 New Jersey 155 Nebraska 10 Maryland 149 Missouri 10 Massachusetts 134 Iowa 10 Washington 123 Hawaii 10 Virginia 105 Kentucky 8 Arizona 80 Idaho 5 Oregon 74 Delaware 5 North Carolina 69 Arkansas 5 Indiana 58 Mississippi 4 Louisiana 56 West Virginia 3 Colorado 53 Vermont 1 Connecticut 39 South Dakota 1 Minnesota 38 North Dakota 1 Utah 37 Maine 1 Tennessee 37 Kansas 1 Michigan 34 Alaska 1
As Of August 2nd CasesSort by LocationSort by location in no order cases in descending order United States Of America 6,325 Spain 4,577 United Kingdom 2,759 Germany 2,724 France 2,054 Brazil 1,369 Netherlands 927 Canada 803 Portugal 633 Italy 505 Belgium 482 Peru 313 Switzerland 298 Democratic Republic Of The Congo 163 Israel 153 Austria 135 Nigeria 133 Sweden 102 Denmark 101 Ireland 97 Poland 63 Mexico 59 Norway 57 Chile 55 Australia 45 Hungary 42 Slovenia 37 Greece 33 Luxembourg 30 Ghana 30
Vaccination • Utilizes the JYNNEOS vaccine, which the FDA approved for protection against smallpox and monkeypox in people ages 18 years and older who are at high risk for monkeypox infection. • Can be used in those under 18 with special approval • CDC is currently recommending the following people should be considered prophylaxis vaccine: • People who have had an exposure to monkeypox that puts them at risk for infections within the last 14 days • People who know that a sex partner in the past 14 days received a monkeypox diagnosis • People who have had multiple sex partners in the past 14 days in a jurisdiction with known monkeypox
Monkeypox • Cases in Children o Health officials in the US have confirmed at least 5 monkeypox cases in children • At this time, the primary risk of spread to children is contact with a household member with monkeypox • Risk of rash in students being monkeypox is exceptionally low • Risks in schools is considered low at this time. Transmission requires extensive direct contact or prolonged face to face contact. • Following the general guidance for students and staff that any rash with fever should be checked by a health care provider and they can return once rash has a diagnosis and known to not be contagious, is being treated, or has healed is sufficient at this time
Basic Monkeypox Guidance • Avoid close contact (including sexual contact) and don’t share objects with people who are sick or have a rash. • Do not kiss, hug or touch. • Do not share eating utensils or cups. • Do not touch the bedding or clothing of a sick person. • Wash hands often with soap and water. If soap and water aren’t available, use an alcohol-based hand sanitizer containing at least 60% alcohol. • Keep your hands away from your eyes, nose, and mouth. If you need to touch your face, make sure your hands are clean.
Monkeypox resources • What You Need to Know About Monkeypox https://publichealth.jhu.edu/2022/what-you-need-to-know-about-monkeypox • Detailed factsheet https://www.centerforhealthsecurity.org/our- work/pubs_archive/pubs-pdfs/fact_sheets/monkeypox.pdf • Healthchildren.org: What is Monkeypox? https://www.healthychildren.org/english/health-issues/vaccine-preventable- diseases/pages/what-is-monkeypox.aspx • Frequently Asked Questions https://www.cdc.gov/poxvirus/monkeypox/faq.html
Monkeypox • Please be careful with messaging to avoid inadvertently stigmatizing any community • Discourage stigmatizing or hate speech in schools; highlight that monkeypox can infect anyone and that the virus is what is making people sick, not any certain activity • Please contact if you have any questions or concerns • We will notify you if any exposures have occurring in your school
Contacts: Jen Morse, MD, MPH, FAAFP jmorse@cmdhd.org Cell: 989-802-2590 For Roscommon, Osceola, Clare, Gladwin, Arenac, Isabella THANKS FOR Counties: Steve Hall, R.S., M.S. shall@cmdhd.org JOINING US! 989-773-5921, Ext. 1421 www.cmdhd.org Any Question? For Missaukee, Crawford, Kalkaska, Wexford, Lake, Mason, Manistee, Oceana, Newaygo, Mecosta Counties: Kevin Hughes, MA khughes@dhd10.org (231) 876-3839 www.dhd10.org For Montcalm, Gratiot, Clinton Counties Liz Braddock MS, RS Cell: 616 302 6301 lbraddock@mmdhd.org www.mmdhd.org
You can also read